UW researchers develop tool to equitably distribute limited vaccines
The demand for COVID-19 vaccines continues to outpace supply, forcing public health officials to decide who should be first in line for a shot, even among those in the same pool of eligible vaccine recipients.
Jamey Weichert, Zachary Morris leading a team to develop new way to help immune system fight back against cancer
Scientists at the University of Wisconsin School of Medicine and Public Health are breaking new ground to make cancer cells more susceptible to attack by the body’s own immune system.
New statewide data show evidence of four-fold increase in recent COVID-19 infections
Preliminary results from the second wave of a UW–Madison study estimated 6.8% of Wisconsin residents have evidence of recent infection of COVID-19.
UW vision researchers partner with U.S. Department of Defense to develop stem cell therapy for combat-related eye injuries
Using an ingenious microscopic retinal patch, eye researchers at UW–Madison will develop and test a new way to treat United States military personnel blinded in combat.
First-in-humans clinical trial to treat children with relapsed neuroblastoma opens at American Family Children’s Hospital
A first-in-humans clinical trial for children with relapsed or refractory neuroblastoma has opened at American Family Children’s Hospital (AFCH) and is being conducted by researchers at University of Wisconsin School of Medicine and Public Health. Neuroblastoma is one of the most common solid tumors in children. Patients who are classified as “high-risk” (about 40 percent of those diagnosed) have less than a 50 percent survival rate.
UW set to resume enrollment for AstraZeneca’s investigational COVID-19 vaccine
A clinical trial of an investigational COVID-19 vaccine has resumed in the United States after the FDA and an independent safety review board completed their review of a trial participant in the United Kingdom who became ill.
COVID-19 data model quantifies region-specific impact of social distancing orders
As the COVID-19 pandemic first took hold in regions across the United States in spring 2020, local officials, hoping to quell the spread of the virus, turned to the only actionable defenses available at the time: closing schools and businesses, banning mass gatherings, issuing stay-at-home orders and enforcing other social distancing measures.
UW studies investigate need for and impact of culturally aware mentorship training
Higher education institutions frequently offer mentored research experiences to increase undergraduate student interest, motivation and preparedness for research careers in Science, Technology, Engineering, Mathematic and Medicine (STEMM) fields.
UW researchers find more precise way to detect pneumonia caused by COVID-19
Using cutting-edge artificial intelligence technology, UW‒Madison investigators have developed a far more precise way to identify cases of COVID-19 induced pneumonia.
UW study looks to keep nursing homes safe during COVID-19 pandemic with telehealth
A new research study at the University of Wisconsin School of Medicine and Public Health seeks to reduce COVID-19 spread in Wisconsin nursing homes by collaborating with community and academic partners to expand telehealth infrastructure.
Stem cells can repair Parkinson’s-damaged circuits in mouse brains
The mature brain is infamously bad at repairing itself following damage like that caused by trauma or strokes, or from degenerative diseases like Parkinson’s. Stem cells, which are endlessly adaptable, have offered the promise of better neural repair. But the brain’s precisely tuned complexity has stymied the development of clinical treatments.
Thriving community of postdocs play valuable role in campus research
National Postdoc Appreciation Week may have only been five days long, but postdoctoral trainees’ profound impact on the University of Wisconsin School of Medicine and Public Health, and the entire university, is on display year-round.